ClearBridge Investments
UTHR icon

ClearBridge Investments’s United Therapeutics UTHR Stock Holding History

ClearBridge Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-515
Closed -$49K – 1055
2020
Q1 		$49K Sell
515
-20
-4% -$1.9K ﹤0.01% 778
2019
Q4 		$47K Sell
535
-1
-0.2% -$88 ﹤0.01% 836
2019
Q3 		$43K Sell
536
-5
-0.9% -$403 ﹤0.01% 833
2019
Q2 		$42K Buy
541
+81
+18% +$7.57K ﹤0.01% 834
2019
Q1 		$54K Sell
460
-2
-0.4% -$233 ﹤0.01% 830
2018
Q4 		$50K Buy
462
+202
+78% +$23.4K ﹤0.01% 852
2018
Q3 		$33K Sell
260
-1
-0.4% -$124 ﹤0.01% 954
2018
Q2 		$30K Sell
261
-1
-0.4% -$110 ﹤0.01% 927
2018
Q1 		$29K Hold
262
– – ﹤0.01% 934
2017
Q4 		$39K Buy
262
+1
+0.4% +$127 ﹤0.01% 891
2017
Q3 		$31K Buy
261
+8
+3% +$1.02K ﹤0.01% 970
2017
Q2 		$33K Buy
+253
New +$31.6K ﹤0.01% 931

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments's UTHR Position: Q2 2020 in Review

ClearBridge Investments sold out of United Therapeutics (UTHR) in Q2 2020, closing a stake of 515 shares — an estimated $49K sold.

ClearBridge Investments first reported a position in UTHR in Q2 2017 and held it in 12 quarters. The position peaked at $54K in Q1 2019. 349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

  • ClearBridge Investments reported no remaining United Therapeutics position as of Q2 2020 after selling out during the quarter.
  • ClearBridge Investments sold 515 United Therapeutics shares in Q2 2020, an estimated $49K.
  • ClearBridge Investments first reported a position in United Therapeutics in Q2 2017 and held it in 12 quarters.
  • ClearBridge Investments's United Therapeutics position peaked at $54K in Q1 2019.
  • 349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on ClearBridge Investments's 13F filing for Q2 2020, filed 14 Aug 2020.